Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Microbot Medical Inc. (MBOT : NSDQ)
 
 • Company Description   
Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Number of Employees: 3

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.00 Daily Weekly Monthly
20 Day Moving Average: 18,815 shares
Shares Outstanding: 7.11 (millions)
Market Capitalization: $35.54 (millions)
Beta: 3.98
52 Week High: $9.60
52 Week Low: $4.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.75% -14.58%
12 Week -13.79% -6.83%
Year To Date -33.33% -21.03%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
25 RECREATION PARK DRIVE UNIT 108
-
HINGHAM,MA 02043
USA
ph: 781-875-3605
fax: 781-556-5347
mpolyviou@evcgroup.com http://www.microbotmedical.com
 
 • General Corporate Information   
Officers
Harel Gadot - Chief Executive Officer; Chairman and President
David Ben Naim - Chief Financial Officer
Yoseph Bornstein - Director
Prattipati Laxminarain - Director
Scott Burell - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 59503A204
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/16/22
Share - Related Items
Shares Outstanding: 7.11
Most Recent Split Date: 9.00 (0.07:1)
Beta: 3.98
Market Capitalization: $35.54 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.42 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.62 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/16/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.47
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -2.86%
vs. Previous Quarter: -2.86%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -60.58
09/30/21 - -47.70
ROA
03/31/22 - -
12/31/21 - -54.85
09/30/21 - -43.87
Current Ratio
03/31/22 - -
12/31/21 - 8.00
09/30/21 - 13.47
Quick Ratio
03/31/22 - -
12/31/21 - 8.00
09/30/21 - 13.47
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 2.02
09/30/21 - 2.51
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©